Lack of JAK2 activating non-synonymous mutations in diffuse large B-cell tumors: JAK2 deregulation still unexplained

Authors

Thomas E. Witzig, Mayo Clinic
Tammy L. Price-Troska, Mayo Clinic
Mary J. Stenson, Mayo Clinic
Mamta Gupta, Mayo Clinic

Document Type

Letter to the Editor

Publication Date

2-1-2013

Journal

Leukemia and Lymphoma

Volume

54

Issue

2

DOI

10.3109/10428194.2012.708931

APA Citation

Witzig, T., Price-Troska, T., Stenson, M., & Gupta, M. (2013). Lack of JAK2 activating non-synonymous mutations in diffuse large B-cell tumors: JAK2 deregulation still unexplained. Leukemia and Lymphoma, 54 (2). http://dx.doi.org/10.3109/10428194.2012.708931